Elkfork Partners’s Emergent Biosolutions EBS Stock Holding History

Elkfork Partners’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$457K	Buy	8,738 +680	+8%	+$31.7K	0.01%	607
2019 Q2	$389K	Buy	8,058 +102	+1%	+$4.89K	0.01%	652
2019 Q1	$402K	Hold	7,956	–	–	0.01%	618
2018 Q4	$472K	Buy	7,956 +34	+0.4%	+$2.19K	0.01%	532
2018 Q3	$521K	Buy	7,922 +34	+0.4%	+$1.98K	0.01%	582
2018 Q2	$398K	Hold	7,888	–	–	0.01%	600
2018 Q1	$415K	Buy	7,888 +986	+14%	+$49.1K	0.01%	584
2017 Q4	$321K	Buy	6,902 +1,190	+21%	+$50.1K	0.01%	660
2017 Q3	$231K	Buy	5,712 +1,598	+39%	+$57.8K	0.01%	694
2017 Q2	$139K	Buy	4,114 +2,074	+102%	+$64K	﹤0.01%	784
2017 Q1	$59K	Sell	2,040 -1,972	-49%	-$60K	﹤0.01%	864
2016 Q4	$132K	Buy	+4,012	New	+$120K	﹤0.01%	671

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Elkfork Partners's EBS Position: Q3 2019 in Review

Elkfork Partners increased its Emergent Biosolutions (EBS) stake by 8.4% in Q3 2019, buying an estimated $31.7K and bringing the position to 8,738 shares worth $457K. The position accounts for 0.01% of the portfolio, ranked #607.

Elkfork Partners first reported a position in EBS in Q4 2016 and has held it in 12 quarters since. The position peaked at $521K in Q3 2018. 244 funds tracked by Wall St. Rank hold EBS as of Q3 2019.

Elkfork Partners held 8,738 shares of Emergent Biosolutions worth $457K as of Q3 2019.
Elkfork Partners bought 680 Emergent Biosolutions shares in Q3 2019, an estimated $31.7K.
Emergent Biosolutions made up 0.01% of Elkfork Partners's portfolio in Q3 2019, its #607 holding.
Elkfork Partners first reported a position in Emergent Biosolutions in Q4 2016 and has held it in 12 quarters since.
Elkfork Partners's Emergent Biosolutions position peaked at $521K in Q3 2018.
244 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.